The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differential activity of PARP inhibitors in BRCA1- versus BRCA2-altered metastatic castration-resistant prostate cancer (mCRPC).
 
Fadi Taza
No Relationships to Disclose
 
Albert E Holler
Stock and Other Ownership Interests - CareDX
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma
Research Funding - Genentech (Inst); Merck (Inst)
 
Ryan Ashkar
No Relationships to Disclose
 
Alexandra Sokolova
No Relationships to Disclose
 
Adam Kessel
No Relationships to Disclose
 
Nellie Nafissi
No Relationships to Disclose
 
Pedro C. Barata
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Caris Life Sciences; Clovis Oncology (Inst); Dendreon (Inst); Eisai; EMD Serono; Pfizer
Research Funding - Blue Earth Diagnostics (Inst)
 
Diogo Assed Bastos
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - Bayer; Janssen-Cilag; MSD Oncology; Roche
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag
 
Oren Smaletz
Honoraria - AstraZeneca
Consulting or Advisory Role - Astellas Pharma; Pfizer
Research Funding - Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; ipsen
 
Rahul Raj Aggarwal
Honoraria - Clovis Oncology
Consulting or Advisory Role - AstraZeneca; Dendreon; Janssen
Research Funding - Abbvie (Inst); Amgen (Inst); Cancer Targeted Technology (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - Xynomic Pharma
 
Jacob E Berchuck
No Relationships to Disclose
 
Panagiotis J. Vlachostergios
No Relationships to Disclose
 
Christopher Su
No Relationships to Disclose
 
Catherine Handy Marshall
Consulting or Advisory Role - McGraw-Hill Education
Research Funding - Conquer Cancer Foundation/Bristol-Myyers Squibb
Travel, Accommodations, Expenses - Dava Oncology
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Lilly; Merck; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi